Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.

How to buy Accelerate Diagnostics stock in Canada | $7.59

Own Accelerate Diagnostics shares in just a few minutes.

Accelerate Diagnostics, Inc
-$0.22 (-2.88%)

Accelerate Diagnostics is a diagnostics & research business based in the US. Accelerate Diagnostics stocks (AXDX.US) are listed on the NASDAQ and all prices are listed in US Dollars. Its last market close was $7.19 – an increase of 10.16% over the previous week. Accelerate Diagnostics employs 224 staff and has a trailing 12-month revenue of around $11.3 million.

How to buy Accelerate Diagnostics stock in Canada

  1. Choose a platform. If you're a beginner, our stock trading table below can help you choose.
  2. Open your account. You'll need your ID, bank details and national insurance number.
  3. Confirm your payment details. You'll need to fund your account with a bank transfer, debit card or credit card.
  4. Search the platform for stock code: AXDX in this case.
  5. Research Accelerate Diagnostics stocks. The platform should provide the latest information available.
  6. Buy your Accelerate Diagnostics stocks. It's that simple.

How has Coronavirus impacted Accelerate Diagnostics's stock price?

Since the stock market crash in March caused by coronavirus, Accelerate Diagnostics's stock price has had significant negative movement.

Its last market close was $7.59, which is 52.94% down on its pre-crash value of $16.13 and 67.55% up on the lowest point reached during the March crash when the stocks fell as low as $4.53.

If you had bought $1,000 worth of Accelerate Diagnostics stocks at the start of February 2020, those stocks would have been worth $346.61 at the bottom of the March crash, and if you held on to them, then as of the last market close they'd be worth $443.64.

Accelerate Diagnostics stock price

Use our graph to track the performance of AXDX stocks over time.

Accelerate Diagnostics stocks at a glance

Information last updated 2021-07-29.
Latest market close$7.59
52-week range$6.44 - $17.82
50-day moving average $7.7686
200-day moving average $8.7843
Wall St. target price$13
Dividend yield N/A (0%)
Earnings per share (TTM) $-1.599

Compare online stock trading platforms

Note: The dollar amounts in the table below are in Canadian dollars.

Name Product Available Asset Types Stock Fee Option Fee Account Fee ETF Transaction Cost Feature Table description
Wealthsimple Trade
Stocks, ETFs
Get a $50 bonus when you open a Wealthsimple Trade account and deposit and trade at least $100.
Pay no commissions when you trade Canadian stocks and ETFs with Wealthsimple Trade.
Scotia iTRADE
Bonds, Options, Mutual Funds, ETFs, GICs, International Equities
$9.99 + $1.25 contract ($4.99 + $1.25 contract if completed 150 trades or more a quarter)
$9.99 ($4.99 if completed 150 trades or more a quarter)
Pay no annual account fees.
Buy, sell and trade ETFs, Equities, Options and more with competitive commissions.
CIBC Investor's Edge
Stocks, Bonds, Options, Mutual Funds, ETFs
$4.95 - $6.95
$4.95 - $6.95 (+$1.25 per contract)
$0 if conditions met, otherwise $100/year
$4.95 - $6.95 is applicable for online stock, ETF and option trades only. Pay $4.95 when you qualify as an Active Trader (trade 150+ times per quarter).
An intuitive and easy-to-use platform with access to a variety of tools that help you make smart decisions and trade with confidence.
Interactive Brokers
Stocks, Bonds, Options, ETFs, Currencies, Futures
Min. $1.00, Max. 0.5% of trade value
$1.50 min. per order
Min. $1.00, Max. 0.5% of trade value
Extensive trading capabilities and global investment tracking.
Access market data 24 hours a day, six days a week and invest in global stocks, options, futures, currencies, bonds and funds from one single account.
Stocks, Bonds, Options, Mutual Funds, ETFs, GICs, International Equities, Precious Metals
$9.95 + $1 per contract
Get $50 in free trades when you fund your account with a minimum of $1,000.
Opt for self-directed investing and save on fees or get a pre-built portfolio and take some of the guesswork out.
Qtrade Direct Investing
Stocks, Bonds, Options, Mutual Funds, ETFs, GICs
$6.95 - $8.75
$6.95 - $8.75 + $1.25 per contract
$0 if conditions met, otherwise $25/quarter
$0 - $8.75
Trade 100 select ETFs free of charge.
Qtrade Direct Investing offers low trading commissions and an easy-to-use platform with access to powerful tools and a wide selection of investment options. Trade 100 ETFs free of charge and thousands more for $8.75 or lower.

Compare up to 4 providers

Online stock trading

Is it a good time to buy Accelerate Diagnostics stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

Accelerate Diagnostics price performance over time

Historical closes compared with the last close of $7.59

1 month (2021-07-02) -4.53%
3 months (2021-04-30) 3.83%

Accelerate Diagnostics financials

Revenue TTM USD$11.3 million
Gross profit TTM USD$4.5 million
Return on assets TTM -38.56%
Return on equity TTM 0%
Profit margin 0%
Book value $0.187
Market capitalisation USD$442 million

TTM: trailing 12 months

How to short and sell Accelerate Diagnostics stocks

  1. Create a CFD or spread betting account.
  2. Search for the stock code. E.g. "AXDX.US"
  3. Choose your position size.
  4. Select "sell" rather than "buy".
  5. Confirm your position and keep tabs on it. You may wish to set limits on your position.

There are currently 7.8 million Accelerate Diagnostics stocks held short by investors – that's known as Accelerate Diagnostics's "short interest". This figure is 0.9% up from 7.8 million last month.

There are a few different ways that this level of interest in shorting Accelerate Diagnostics stocks can be evaluated.

Accelerate Diagnostics's "short interest ratio" (SIR)

Accelerate Diagnostics's "short interest ratio" (SIR) is the quantity of Accelerate Diagnostics stocks currently shorted divided by the average quantity of Accelerate Diagnostics stocks traded daily (recently around 175474.16032244). Accelerate Diagnostics's SIR currently stands at 44.66. In other words for every 100,000 Accelerate Diagnostics stocks traded daily on the market, roughly 44660 stocks are currently held short.

However Accelerate Diagnostics's short interest can also be evaluated against the total number of Accelerate Diagnostics stocks, or, against the total number of tradable Accelerate Diagnostics stocks (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Accelerate Diagnostics's short interest could be expressed as 0.13% of the outstanding stocks (for every 100,000 Accelerate Diagnostics stocks in existence, roughly 130 stocks are currently held short) or 0.2832% of the tradable stocks (for every 100,000 tradable Accelerate Diagnostics stocks, roughly 283 stocks are currently held short).

A SIR above 20% would generally be considered very high, pointing to a pessimistic outlook for the stock price, with a discouraging number of investors currently willing to bet against Accelerate Diagnostics.

Find out more about how you can short Accelerate Diagnostics stock.

Accelerate Diagnostics stock dividends

We're not expecting Accelerate Diagnostics to pay a dividend over the next 12 months. However, you can browse other dividend-paying stocks in our guide.

Accelerate Diagnostics stock price volatility

Over the last 12 months, Accelerate Diagnostics's stocks have ranged in value from as little as $6.44 up to $17.82. A popular way to gauge a stock's volatility is its "beta".

AXDX.US volatility(beta: 1.96)Avg. volatility(beta: 1.00)LowHigh

Beta is a measure of a stocks volatility in relation to the market. The market (NASDAQ average) beta is 1, while Accelerate Diagnostics's is 1.9581. This would suggest that Accelerate Diagnostics's stocks are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).

Accelerate Diagnostics overview

Accelerate Diagnostics, Inc., an in vitro diagnostics company, provides solutions for the diagnosis of serious infections in the United States, Europe, and the Middle East. The company offers Accelerate Pheno system, an in vitro diagnostic platform for the identification and antibiotic susceptibility testing of pathogens associated with serious or health care-associated infections, including gram-positive and gram-negative organisms. It also provides the Accelerate PhenoTest, a test kit for the system, which provides identify and antibiotic susceptibility testing results for patients suspected of bacteremia or fungemia, both life-threatening conditions with high morbidity and mortality risk. The company was formerly known as Accelr8 Technology Corporation and changed its name to Accelerate Diagnostics, Inc. in December 2012. Accelerate Diagnostics, Inc. was founded in 1982 and is headquartered in Tucson, Arizona.

Frequently asked questions

Disclaimer: This information should not be interpreted as an endorsement of futures, stocks, ETFs, CFDs, options or any specific provider, service or offering. It should not be relied upon as investment advice or construed as providing recommendations of any kind. Futures, stocks, ETFs and options trading involves substantial risk of loss and therefore are not appropriate for all investors. Trading CFDs and forex on leverage comes with a higher risk of losing money rapidly. Past performance is not an indication of future results. Consider your own circumstances, and obtain your own advice, before making any trades.

More on investing

More guides on Finder

Go to site